• next page
  • next page

J.P. Morgan Corporate Challenge in Frankfurt, 12th of June, 2019.

On 12th of June this year's J.P. Morgan Corporate Run again took place in Frankfurt. The J.P. Morgan Corporate Challenge is a worldwide series of running events for salaried employees that will take place in 2019 in 5 continents, 7 countries and 13 cities. 9 Valicare employees took part together with their Bosch colleagues and over 60,000 runners from 2,282 companies. The 5.6 km long route led through downtown Frankfurt with the goal of the Senkenberg plant.

The J.P. Morgan race is not primarily about the sporting ambition and success of the individual, it is much more a team event in which collegiality, communication, fairness and fun are the focus and which above all serves a good cause.

This time, the cash of the runners, which is basically doubled by JP Morgan (a leading US financial service provider), raised a total of 252,000 Euros, which will be donated to Deutsche Sporthilfe and Deutsche Behindertensportjugend. Since 2007, 2.8 million euros have been collected so far.

After the run through the city centre, the participants met at the company meeting points, which were set up in the green areas or on the banks of the Main, to round off the evening with barbecue sausages and cool drinks together with nice colleagues.

There is an agreement among the runners from Valicare, that after the start is before the start!


Further information

Dr Claudia Papewalis is giving a GMP for ATMP training


If you want to know more about the regulatory requirements requested for manufacturing ATMPs, contact our experts or take part at one of our internal GMP training courses.

A scientist is looking at t-cells visible at a computer screen

GMP-compliant manufacturing process

Valicare supports start-ups like polybiocept in transferring cell-culturing methods developed at the laboratory into a GMP-compliant manufacturing process. Check the press release and get an overview about our GMP for ATMP services.

cell culture, ATMPs

„Guidelines on Good Manufacturing Practice (GMP) specific to Advanced Therapy Medicinal Products”

On 22th of November 2017 the European Commission adopted the "Guidelines on Good Manufacturing Practices (GMP) specific to Advanced Therapy Medicinal Products".